»ó´Ü¿©¹é
±â»ç (Àüü 61,605°Ç)
GC³ì½ÊÀÚÀ£ºù, '¶óÀ̳Ø' ±Ù°¨¼ÒÁõ ¿¹¹æÈ¿°ú ±¹Á¦ ÇмúÁö °ÔÀç ¹Úº´¿ì ±âÀÚ 2019-02-20 10:12
JW±×·ì, â¾÷ÀÚ Íº ¼ºÃµ(àøô») À̱⼮¼±»ý 44±â Ãßµµ½Ä ±è»ç¶û ±âÀÚ 2019-02-20 10:10
ºñ¾¾¿ùµåÁ¦¾à, ÁÖÁÖÃÑȸ¼ÒÁý °áÀÇ(2/20) ±è»ç¶û ±âÀÚ 2019-02-20 09:50
Á¾±Ù´ç, ¾ó±¼ ¸®ÇÁÆÃ¿ë ³ì´Â ½Ç ¡®½ÇÅ©·Îµå¡¯ 5Á¾ ±è»ç¶û ±âÀÚ 2019-02-20 09:47
CJÇコÄɾî, 1ºÐ±â 'CP Change Agent ½ÉÈ­±³À°¡¯ ÁøÇà ¹Úº´¿ì ±âÀÚ 2019-02-20 09:44
¶óÀÎ
´ë¿õÁ¦¾à, ¡°FDA ¡®¸ÞµðÅ彺¡¯ û¿ø °ÅºÎ"¡¦Ú¸ ÁøÃâ ¼øÇ× ±è»ç¶û ±âÀÚ 2019-02-20 09:40
ºÎ±¤¾àÇ°, ½Å¾à JM-010 Ú¸ INDÁ¦Ãâµî R&D 'È°¹ß' ±è»ç¶û ±âÀÚ 2019-02-20 09:37
¼¿¸®µå, »óÀå ù³¯ °ø¸ð°¡ ´ëºñ 45%»ó½Â '±Þµî¼¼' ±è»ç¶û ±âÀÚ 2019-02-20 09:14
Á¦¾à-SK Pharma Weekly(2/13~19) ¹Úº´¿ì ±âÀÚ 2019-02-20 08:08
ÇコÄɾî Daily(2/20)-½ÅÇѱÝÀ¶ÅõÀÚ ¹Úº´¿ì ±âÀÚ 2019-02-20 08:00
¶óÀÎ
Á¦ÀÌÆÊ ±èÁ¤¼± ´ëÇ¥ ¾Æµé(3/2) ÆʽºÅ¹ 2019-02-20 07:25
½ÄÇ°ÀǾàÇ°¾ÈÀüó °úÀå±Þ ÆʽºÅ¹ 2019-02-20 07:23
Æĸã½Å, ±Û·Î¹ú °æÀï·ÂÀ» °®Ãá ±¹»ê1È£ Ç×ü½Å¾à ¹Úº´¿ì ±âÀÚ 2019-02-20 07:01
½ÅdzÁ¦¾à, »çȸ°øÇåÈ°µ¿ ÅëÇØ »ç¶û ³ª´® ½Çõ¿¡ ¾ÕÀå ±è»ç¶û ±âÀÚ 2019-02-20 06:45
¹ÙÀÌ¿À, 1Á¶¿ø´ë ºí·Ï¹ö½ºÅÍ 5°³ âÃâÇÑ´Ù ±è»ç¶û ±âÀÚ 2019-02-20 06:30
¶óÀÎ
³ªÀ̺¤, 87¾ï±Ô¸ð ¸»»ÀÀ¯·¡ Ä¡°ú¿ë °ñÀ̽ÄÀç °è¾à ÇØÁö ¹Úº´¿ì ±âÀÚ 2019-02-19 18:48
³ªÀ̺¤, ´ÜÀÏÆǸŤý°ø±Þ°è¾àÇØÁö(2/19) ¹Úº´¿ì ±âÀÚ 2019-02-19 18:38
¾ÈÆ®·ÎÁ¨, ¸ÅÃâ¾× ¶Ç´Â ¼ÕÀͱ¸Á¶ 30%(´ë±Ô¸ð¹ýÀÎÀº 15%)ÀÌ»ó º¯µ¿(2/19) ±è»ç¶û ±âÀÚ 2019-02-19 17:54
¼¿¸®µå, ÄÚ½º´Ú ½Å±Ô »óÀå½ÂÀÎ ³»ÀÏ(20ÀÏ)ºÎÅÍ °Å·¡ °³½Ã ±è»ç¶û ±âÀÚ 2019-02-19 17:51
°­½ºÅÛ¹ÙÀÌ¿ÀÅØ, ±âŸ °æ¿µ»çÇ×(ƯÇã±Ç Ãëµæ)(ÀÚÀ²°ø½Ã)(2/19) ±è»ç¶û ±âÀÚ 2019-02-19 17:44
Back to Top